|
Productname |
 CIC-C1q MicroVue™ Quidel® |
|
|
Quantification of circulating immune complexes |
|
Cat-No. |
A001 |
|
|
A013 CIC Control 1 Set (2 levels)
|
|
Range |
10 - 30 µg Eq/ml |
|
Sensitivity |
1.0 µg Eq/ml |
|
Incubation time |
2 hours |
|
Sample volume |
10 µl (dilute 1:50) |
|
Sample type |
Serum and plasma
|
|
Sample preparation |
All specimens should be collected aseptically and prepared using standard techniques for clinical laboratory testing. Do not heat-inactivate the specimens. Sample may be stored at 2-8 ºC for up to 7 days. For longer periods store below -20ºC.
|
|
Reference values |
One hundred six (106) sera were collected from normal, asymptomatic subjects. The average CIC concentration was 2.1 µg Eq/mL (S.D.=1.9)
|
|
Species |
Human
|
|
Specificity |
Complement-CICs are bound to immobilized to C1q-Protein.
|
|
Tests |
96 Tests |
|
Method |
ELISA |
|
Product informations |
- Literature: Complement Diagnostics (pdf-File 1,850 kb)
- Kit Instructions (pdf-File 269 kb)
- Cross-reaction all species (pdf-File 71 kb)
- Datasheet (pdf-File 511 kb) |
|
Intended use |
The CIC-C1q Assay is designed for the detection of circulating immune complexes (CIC) in human serum or plasma. CIC have been measured in a variety of conditions: infections, autoimmune disorders, trauma and neoplastic proliferative diseases. In addition the measurement of CIC can be important for the evaluation of certain forms of rheumatoid arthritis and for monitoring the effectiveness of therapy.
|
|
Keywords product |
CIC-C1q, ELISA, Quantification of circulating immune complexes, Rheumatoid Arthritis, Complement pathway, Complement cascade
|